Literature DB >> 8372417

[Nuclear magnetic resonance tomography for improving the differential diagnosis of pathologic changes in the scrotal contents].

H Derouet1, H U Braedel, G Brill, K Hinkeldey, J Steffens, M Ziegler.   

Abstract

A total of 75 patients with scrotal pathology were examined using magnetic resonance imaging (MRI). The diagnostic results were compared with operative and histological findings and with the sonographic results available. Compared with sonography, MRI showed diagnostic advantages in the detection and characterization of malignant tumors and in the exclusion of non-tumorous testicular pathology (old torsions, periorchitis, old hematomas). No false-negative results were found by MRI. False-positive results were found in 2 out of 75 MRI examinations. The possibility of showing tunica albuginea, of imaging testes in various planes and its diagnostic accuracy of about 88% as well as the lack of ionizing irradiation make MRI the most reliable form of diagnostic imaging in the classification of scrotal pathology. Sonography (51/75) showed high sensitivity in detecting testicular disease (90%), but its specificity (55%) was disappointing and could not be quantified with regards to the differentiation of testicular cancer.

Entities:  

Mesh:

Year:  1993        PMID: 8372417

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  3 in total

1.  [Tubular ectasia of rete testis: a pitfall in ultrasonographic diagnostics of intratesticular cysts].

Authors:  K-P Dieckmann; U Frey; B Feyerabend; A Pust; G Lock
Journal:  Urologe A       Date:  2011-01       Impact factor: 0.639

Review 2.  Conservative management of polyorchidism in a young man: a case report and review of literature.

Authors:  Ricky H Bhogal; Amitabh Palit; Krishna K Prasad
Journal:  Pediatr Surg Int       Date:  2006-11-11       Impact factor: 1.827

Review 3.  Contemporary diagnostic work-up of testicular germ cell tumours.

Authors:  Klaus-Peter Dieckmann; Ulrich Frey; Guntram Lock
Journal:  Nat Rev Urol       Date:  2013-11-12       Impact factor: 14.432

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.